Xuemei Yang
Zhuhai, 519020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
5,7-dimethoxyflavone inhibits hepatocellular carcinoma progression via increasing intestinal Akkermansia muciniphila and hepatic CD8+ T cell infiltration.
Journal: Chinese medicine
Published: June 08, 2025
Baicalin promotes anti-tumor immunity in hepatocellular carcinoma through HIF-1α/Lactate/CXCL9 axis.
Baicalin promotes anti-tumor immunity in hepatocellular carcinoma through HIF-1α/Lactate/CXCL9 axis.
Journal: Biochemical pharmacology
Published: February 22, 2025
Biejiajian Pill Regulates Ferroptosis in Hepatocellular Carcinoma Cells via p62/Keap1/NRF2 Signaling Pathway: A Mechanism Study
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: November 26, 2024
Erratum: MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2: Erratum.
Journal: Journal of Cancer
Published: December 09, 2022
Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRβ signaling in cancer-associated fibroblasts.
Journal: Journal of ethnopharmacology
Published: August 14, 2022
Baicalin inhibits hepatocellular carcinoma cell growth and metastasis by suppressing ROCK1 signaling.
Journal: Phytotherapy research : PTR
Published: January 16, 2022
Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5.
Journal: Frontiers in pharmacology
Published: September 05, 2021
Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma.
Journal: Frontiers in pharmacology
Published: September 25, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026